Allergy (journal)

Last updated

History

The journal' was established by Ernst B. Salén as Acta Allergologica and was first published by Einer Munksgard in 1948. Salén was also the original editor-in-chief, however, Egon Bruun also helped in the early years. Other editors-in-chief have been Gunnar Bendixen (1970–1992), Gunnar S. Johansson (1993–2002), Jean Bousquet (2003–2009), Thomas Bieber and Hans-Uwe Simon (2010–2017), and the current editor-in-chief Cezmi Akdis (March 2018–present). [3]

Related Research Articles

<span class="mw-page-title-main">Allergen immunotherapy</span> Medical treatment for environmental allergies

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergens in an attempt to change the immune system's response.

Nambudripad's Allergy Elimination Techniques (NAET) is a form of alternative medicine which proponents claim can treat allergies and related disorders. The techniques were devised by Devi Nambudripad, a California-based chiropractor and acupuncturist, in 1983, drawing on a combination of ideas from applied kinesiology, acupuncture, acupressure, nutritional management, and chiropractic methods.

<span class="mw-page-title-main">Eosinopenia</span> Medical condition

Eosinopenia is a condition where the number of eosinophils, a type of white blood cell, in circulating blood is lower than normal. Eosinophils are a type of granulocyte and consequently from the same cellular lineage as neutrophils, basophils, and mast cells. Along with the other granulocytes, eosinophils are part of the innate immune system and contribute to the defense of the body from pathogens. The most widely understood function of eosinophils is in association with allergy and parasitic disease processes, though their functions in other pathologies are the subject of ongoing research. The opposite phenomenon, in which the number of eosinophils present in the blood is higher than normal, is known as eosinophilia.

<i>The Journal of Allergy and Clinical Immunology</i> Academic journal

The Journal of Allergy and Clinical Immunology (JACI) is a monthly peer-reviewed medical journal covering research on allergy and immunology. It is one of three official journals of the American Academy of Allergy, Asthma, and Immunology. The journal was established in 1929 as the Journal of Allergy and obtained its current name in 1971. The name change was purportedly related to a change in the attitude among physicians about the breadth of applicability of the term "allergy". The journal has been published under the Mosby imprint since its inception.

The Swiss Institute of Allergy and Asthma Research (SIAF) was founded in 1988 as an institution of the foundation Schweizerisches Forschungsinstitut für Hochgebirgsklima und Medizin SFI in Davos, Switzerland. SIAF is located at the Medicine Campus Davos, which opened in 2019. SIAF has been an affiliated institute of the University of Zurich since 1995.

<i>Clinical Microbiology Reviews</i> Academic journal

Clinical Microbiology Reviews is a peer-reviewed medical journal covering the areas of clinical microbiology, immunology, medical microbiology, infectious diseases, veterinary microbiology, and microbial pathogenesis. It is a delayed open access journal, full content is accessible via PubMed Central and the journal's website after a 12-month embargo. In April 2015, the journal transitioned to a continuous online publication model. The journal became online-only in January 2018. The final print issue was published in October 2017. According to the Journal Citation Reports, the journal has a 2023 impact factor of 19.0. The journal was established in January 1988. The founding editor was Josephine A. Morello. Editorial board structure changed in 1992 and Morello became editor-in-chief. Betty Ann Forbes was appointed editor-in-chief in 1997. Irving Nachamkin was appointed editor-in-chief in 2002 until 2012. Jo-Anne H. Young served as editor-in-chief from 2012 to 2022. The current editor-in-chief is Graeme Forrest. It is the ninth journal established and published by the American Society for Microbiology.

<i>Journal of Immunology</i> Academic journal

The Journal of Immunology is a biweekly peer-reviewed medical journal that publishes basic and clinical studies in all aspects of immunology. Established in 1916, it changed its name to Journal of Immunology, Virus Research and Experimental Chemotherapy from 1943 to 1949, then returned to the original Journal of Immunology in 1950. It is the official journal of the American Association of Immunologists. The editor-in-chief is Gail A. Bishop.

Clinical Infectious Diseases is a peer-reviewed medical journal published by Oxford University Press covering research on the pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, and treatment of diseases caused by infectious agents. It includes articles on antimicrobial resistance, bioterrorism, emerging infections, food safety, hospital epidemiology, and HIV/AIDS. It also features highly focused brief reports, review articles, editorials, commentaries, and supplements. The journal is published on behalf of the Infectious Diseases Society of America. The editor-in-chief is infectious disease physician Paul Sax.

The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organisation for European clinicians, researchers and allied health professionals in the field of allergy and clinical immunology, covering asthma, rhinitis, eczema and occupational allergy, food and drug allergy, severe anaphylactic reactions, autoimmune disorders, and immunodeficiencies.

<i>Immunopharmacology and Immunotoxicology</i> Academic journal

Immunopharmacology and Immunotoxicology is a bimonthly peer-reviewed medical journal that covers preclinical and clinical studies on the regulatory effects of various agents on immunocompetent cells, as well as the immunotoxicity exerted by xenobiotics and drugs. Hence, the journal encompasses a broad range of pathologies. It is published by Informa.

<span class="mw-page-title-main">World Allergy Organization</span>

The World Allergy Organization (WAO) is an international umbrella organization of 111 regional and national allergology and clinical immunology societies. Since the first World Allergy Congress (WAC) held in Zurich, Switzerland in 1951, there have been 29 WACs as well as a number of WAO International Science Conferences (WISC), Webinars, and Symposia. Beyond sharing research findings, these meetings also allocate funds for postgraduate programs on allergy and clinical immunology.

Torsten Zuberbier is a German dermatologist and allergologist.

Igor Petrovych Kaidashev is a Ukrainian immunologist and allergist, MD, and Professor. Igor Kaidashev is President of the Ukrainian Society of Immunology, Allergy and Immunorehabilitation, Professor of the Department of Internal Medicine No. 3 with Phthisiology, and Vice-Rector for Research & Development at Poltava State Medical University (PSMU) since 2010.

A medical condition is termed heterogeneous, or a heterogeneous disease, if it has several etiologies ; as opposed to homogeneous conditions, which have the same root cause for all patients in a given group. Examples of heterogeneous conditions are hepatitis and diabetes. Heterogeneity is not unusual, as medical conditions are usually defined pathologically, as in "liver inflammation", or clinically, as in "excessive urination", rather than etiologically. Heterogeneous conditions are often divided into endotypes based on etiology.

<span class="mw-page-title-main">Kari Nadeau</span> American Physician and scientist

Kari C. Nadeau is the Chair of the Department of Environmental Health at Harvard School of Public Health and John Rock Professor of Climate and Population Studies. She is adjunct professor at Stanford University in the Department of Pediatrics and the co-chair of the Medical Societies Consortium for Climate Change and Health. She practices Allergy, Asthma, Immunology in children and adults. She has published over 400+ papers, many in the field of climate change and health. Her team focuses on quantifying health outcomes of solutions as they pertain climate change mitigation and adaptation at the local, regional, country, and global levels. Dr. Nadeau, with a team of individuals and patients and families, has been able to help major progress and impact in the clinical fields of immunology, infection, asthma, and allergy. Dr. Nadeau is a member of the National Academy of Medicine and the U.S. EPA Children’s Health Protection Committee.

Pediatric Allergy and Immunology is a peer-reviewed medical journal covering immunology and allergy as they relate to pediatrics. It was established in 1990 and is published eight times per year by John Wiley & Sons. It is the official journal of the European Academy of Allergy and Clinical Immunology. The editor-in-chief is Philippe Eigenmann. According to the Journal Citation Reports, the journal has a 2020 impact factor of 6.377, ranking it 6th out of 28 journals in the category "Allergy".

Erika von Mutius is a German pediatrician and allergologist at the Helmholtz Center Munich and the Ludwig-Maximilians-University of Munich. Her research interests include paediatrics, pediatric pneumology, allergology and epidemiology.

Allergy, Asthma & Immunology Research is a bimonthly peer-reviewed open access medical journal covering immunology. It was established in 2009 and is published by the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Academy of Pediatric Allergy and Respiratory Disease; it is an official journal of both societies. The editor-in-chief is Hae-Sim Park. According to the Journal Citation Reports, the journal has a 2018 impact factor of 5.026.

Cezmi Akdis is a medical researcher in the field of immunology. He is director of the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, Switzerland and the editor in chief of the journal Allergy.

<span class="mw-page-title-main">Giorgio Walter Canonica</span> Italian allergist and pulmonologist

Giorgio Walter Canonica is an Italian allergist, pulmonologist and professor of Respiratory Medicine at Humanitas University, Milan, Italy and Director Personalized Medicine Asthma & Allergy Center at Humanitas Research Hospital IRCCS-Milano Italy since December 2016. He is known for his research work related to innovative treatment strategies for allergic diseases which includes biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT). He has served as Secretary General and President elect of World Allergy Organisation for six consecutive years and has served as president of the same organization during 2007–09. He is also the vice-president of INTERASMA.

References

  1. "Editors". Allergy: European Journal of Allergy and Clinical Immunology. EAACI.
  2. "Allergy". 2023 Journal Citation Reports (Science ed.). Clarivate. 2024 via Web of Science.
  3. "Allergy Journal". www.eaaci.org. Archived from the original on 2018-10-19. Retrieved 2019-04-11.